A Phase I Study of XJ101 in Chinese Healthy Subjects

NCT06014736 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Staphylococcus Aureus Bloodstream Infection

Interventions

DRUG: XJ101 for Injection
DRUG: Placebo

Sponsor

Starmab biologics（Shanghai）Co,.ltd